Cross-Site Evaluation of Commercial Sanger Sequencing Chemistries

J Biomol Tech. 2020 Sep;31(3):88-93. doi: 10.7171/jbt.20-3103-002.

Abstract

Sanger sequencing remains an essential tool utilized by researchers. Despite competition from commercial sequencing providers, many academic sequencing core facilities continue to offer these services based on a model of competitive pricing, knowledgeable technical support, and rapid turnaround time. In-house Sanger sequencing remains a viable core service and, until recently, Applied Biosystems BigDye Terminator chemistry was the only commercially available solution for Sanger DNA sequencing on Applied Biosystems (ABI) instruments; however, several new products employing novel dye chemistries and reaction configurations have entered the market. As a result, there is a need to benchmark the performance of these new chemistries on various DNA templates, including difficult-to-sequence templates, and their amenability to commonly employed cost-saving measures, such as dye dilution and reaction miniaturization. To evaluate these new reagents, a study was designed to compare the quality of Sanger sequencing data produced by ABI BigDye and commercially available kits from 2 other vendors using both control and difficult-to-sequence DNA templates under various reaction conditions. This study will serve as a valuable resource to core facilities conducting Sanger sequencing that wish to evaluate the use of an alternative chemistry in their sequencing core.

Keywords: BigDye alternative; BrightDye; BrilliantDye; Sanger chemistry replacement; Sanger dye evaluation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Coloring Agents / chemistry
  • DNA / genetics
  • Sequence Analysis, DNA / methods*
  • Templates, Genetic

Substances

  • Coloring Agents
  • DNA